Provided by Tiger Trade Technology Pte. Ltd.

IDEXX Laboratories

645.06
+9.521.50%
Volume:163.57K
Turnover:104.68M
Market Cap:51.51B
PE:49.32
High:645.45
Open:633.50
Low:630.24
Close:635.54
52wk High:769.98
52wk Low:356.14
Shares:79.85M
Float Shares:79.12M
Volume Ratio:0.50
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):13.08
EPS(LYR):13.08
ROE:66.20%
ROA:25.59%
PB:32.09
PE(LYR):49.32

Loading ...

IDEXX President and CEO Jonathan Jay Mazelsky Disposes of Common Shares

Reuters
·
Mar 03

IDEXX Laboratories Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 03

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2026-03-02

Reuters
·
Mar 03

IDEXX Laboratories Publishes Investor Presentation on Innovation-Driven Veterinary Diagnostics Growth and Software, Data and AI Enablement

Reuters
·
Mar 02

IDEXX EVP Nimrata Hunt Disposes of Common Shares

Reuters
·
Feb 28

Analysts Conflicted on These Healthcare Names: Xenon (XENE), Idexx Laboratories (IDXX) and Warby Parker (WRBY)

TIPRANKS
·
Feb 28

Is It Too Late To Consider IDEXX Laboratories (IDXX) After Strong Multi‑Year Share Price Gains?

Simply Wall St.
·
Feb 26

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 25

Is IDEXX’s (IDXX) Board Transition Shaping Its Strategy Around InVue DX and Recurring Revenue?

Simply Wall St.
·
Feb 23

IDEXX FY 2025 CAG Diagnostics capital instrument revenue jumps 51.8% to USD 200.21 million

Reuters
·
Feb 21

IDEXX Director Sophie V. Vandebroek Disposes of Common Shares

Reuters
·
Feb 20

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 19

IDEXX Laboratories Announces Retirement of Director M. Anne Szostak and Appointment of Michael G. Erickson to Board

Reuters
·
Feb 14

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 14

Should Strong 2025 Results and 2026 Outlook for CAG Diagnostics Recurring Revenue Require Action From IDEXX Laboratories (IDXX) Investors?

Simply Wall St.
·
Feb 13

IDEXX Laboratories Executives to Present at Major Investor Conferences

Reuters
·
Feb 13

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 12

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 11

IDEXX Labs Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Feb 10

Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating

MT Newswires Live
·
Feb 09